SCHEDULE 13G
0001646799
XXXXXXXX
LIVE
Common stock, par value $0.00001 per share
07/01/2025
0001279704
Cellectar Biosciences, Inc.
15117F880
100 Campus Drive
Florham Park
NJ
07932
Rule 13d-1(c)
Mitchell P. Kopin
X1
0.00
140101.00
0.00
130701.00
140101.00
N
4.99
HC
IN
Daniel B. Asher
X1
0.00
140101.00
0.00
130701.00
140101.00
N
4.99
HC
IN
Intracoastal Capital LLC
DE
0.00
140101.00
0.00
130701.00
140101.00
N
4.99
OO
Cellectar Biosciences, Inc.
100 Campus Drive, Florham Park, NJ, 07932
This Schedule 13G is being filed on behalf of (i) Mitchell P. Kopin, an individual ("Mr. Kopin"), (ii) Daniel B. Asher, an individual ("Mr. Asher") and (iii) Intracoastal Capital LLC, a Delaware limited liability company ("Intracoastal" and together with Mr. Kopin and Mr. Asher, collectively the "Reporting Persons").
The principal business office of Mr. Kopin and Intracoastal is 245 Palm Trail, Delray Beach, Florida 33483. The principal business office of Mr. Asher is 1011 Lake Street, Suite 311, Oak Park, Illinois 60301.
Mr. Kopin is a citizen of the United States of America. Mr. Asher is a citizen of the United States of America. Intracoastal is a Delaware limited liability company.
Y
(i) Immediately following the consummation of the underwritten public offering by the Issuer on July 1, 2025 (the "Offering") (as disclosed in the Form 424B4 prospectus filed by the Issuer with the Securities and Exchange Commission on July 2, 2025), each of the Reporting Persons may have been deemed to have beneficial ownership of 150,000 shares of Common Stock held by Intracoastal, and all such shares of Common Stock represent beneficial ownership of approximately 5.6% of the Common Stock, based on 2,677,039 shares of Common Stock outstanding following the consummation of the Offering, as reported by the Issuer. The foregoing excludes 150,000 shares of Common Stock issuable upon exercise of a warrant held by Intracoastal (the "Intracoastal Warrant") because the Intracoastal Warrant contains a blocker provision under which the holder thereof does not have the right to exercise the Intracoastal Warrant to the extent (but only to the extent) that such exercise would result in beneficial ownership by the holder thereof, together with the holder's affiliates, and any other persons acting as a group together with the holder or any of the holder's affiliates, of more than 4.99% of the Common Stock. Without such blocker provision, each of the Reporting Persons may have been deemed to have beneficial ownership of 300,000 shares of Common Stock.
(ii) As of the close of business on July 8, 2025, each of the Reporting Persons may have been deemed to have beneficial ownership of 140,101 shares of Common Stock, which consisted of (i) 9,500 shares of Common Stock held by Intracoastal and (ii) 130,601 shares of Common Stock issuable upon exercise of the Intracoastal Warrant, and all such shares of Common Stock represent beneficial ownership of approximately 4.99% of the Common Stock, based on (1) 2,677,039 shares of Common Stock outstanding following the consummation of the Offering, as reported by the Issuer, plus (2) 130,601 shares of Common Stock issuable upon exercise of the Intracoastal Warrant. The foregoing excludes 19,399 shares of Common Stock issuable upon exercise of the Intracoastal Warrant because the Intracoastal Warrant contains a blocker provision under which the holder thereof does not have the right to exercise the Intracoastal Warrant to the extent (but only to the extent) that such exercise would result in beneficial ownership by the holder thereof, together with the holder's affiliates, and any other persons acting as a group together with the holder or any of the holder's affiliates, of more than 4.99% of the Common Stock. Without such blocker provision, each of the Reporting Persons may have been deemed to have beneficial ownership of 159,500 shares of Common Stock.
4.99%
0
140,101
0
130,701
N
Y
Y
Y
Y
Y
N
By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under ?? 240.14a-11.
Exhibit 1 - Joint Filing Agreement
Mitchell P. Kopin
/s/ Mitchell P. Kopin
Mitchell P. Kopin
07/08/2025
Daniel B. Asher
/s/ Daniel B. Asher
Daniel B. Asher
07/08/2025
Intracoastal Capital LLC
/s/ Mitchell P. Kopin
Mitchell P. Kopin, Manager
07/08/2025